Join us to celebrate the breadth and excellence of Bournemouth University’s research as part of Interdisciplinary Research Week this May. This is an opportunity to spark new collaborations and ideas among our diverse research community.
This year we have a week long programme of lectures, demonstrations, discussions and a film, which will showcase the fantastic research which is being undertaken at the university.
This is the sixth in a series of blog posts which will highlight the events you can join throughout the week. The sixth event of the programme will take place on Wednesday 13th May, Dr Angela Gosling & Dr Jan Wiener the ability to navigate within complex and rapidly changing environments is a crucial skill humans possess and one that most of us take for granted. Recent reports suggest that increasing numbers of people have deficits to core navigation abilities; current estimates suggest 6 million people in EU countries, a number expected to rise in coming years. Research currently underway in the Navigation Lab at Bournemouth University is aimed at addressing some of the current issues in human navigation. Our novel research focus makes use of state-of-the art eye-tracking and electrical neuroimaging technology to investigate neural and cognitive functions in virtual navigation environments.
This event will take place on Talbot Campus in Barnes Lecture Theatre from 4.00pm-5.30pm, with refreshments available from 5.30pm. You can book your place by clicking here.











BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease